Skip to main content
. 2023 Jun 7;26(1):359. doi: 10.3892/etm.2023.12058

Figure 1.

Figure 1

CX3CL1 expression is reduced in degenerative NP tissues. Analysis of (A) mRNA and (B) protein levels of CX3CL1 in NPs via RT-qPCR and western blotting. Analysis of (C) mRNA and (D) protein levels of CX3CR1 in NPs via RT-qPCR and western blotting. All data were shown as mean ± SD from five independent experiment with each performed in triplicate. *P<0.05 vs. Control group. CX3CL1, CX3C chemokine ligand 1; NPs, nucleus pulposus tissues; RT-qPCR, reverse transcription-quantitative PCR.